D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.14% |
| 2 | Financials | 9.37% |
| 3 | Healthcare | 7.49% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
National Bank Holdings
NBHC
$1.9B
| $761K | ﹤0.01% |
20,573
+13,731
| +201% | +$551K |
|
3627
Inseego
INSG
$111M
| $760K | ﹤0.01% |
36,712
-24,844
| -40% | -$600K |
|
3628
PUT
Medifast
MED
$108M
| $759K | ﹤0.01% |
7,000
-10,000
| -59% | -$1.43M |
|
3629
Mirum Pharmaceuticals
MIRM
$6.84B
| $759K | ﹤0.01% |
36,145
+11,309
| +46% | +$272K |
|
3630
SunCoke Energy
SXC
$779M
| $758K | ﹤0.01% |
130,322
+29,310
| +29% | +$197K |
|
|
SAFE
3631
PUT
Safehold
SAFE
$1.19B
| $756K | ﹤0.01% |
16,764
| – | – |
|
3632
Peloton Interactive
PTON
$2.84B
| $755K | ﹤0.01% |
108,942
-158,329
| -59% | -$1.61M |
|
3633
PUT
Ryder
R
$9.98B
| $755K | ﹤0.01% |
+10,000
| New | +$761K |
|
3634
Doximity
DOCS
$3.85B
| $754K | ﹤0.01% |
24,938
-59,791
| -71% | -$2.19M |
|
3635
Rimini Street
RMNI
$453M
| $753K | ﹤0.01% |
161,780
+24,321
| +18% | +$136K |
|
3636
PUT
Calix
CALX
$2.34B
| $752K | ﹤0.01% |
12,300
| – | – |
|
3637
CALL
SM Energy
SM
$7.11B
| $752K | ﹤0.01% |
+20,000
| New | +$787K |
|
|
WCC
3638
PUT
WESCO International
WCC
$16.1B
| $752K | ﹤0.01% |
+6,300
| New | +$788K |
|
3639
Zegna
ZGN
$4.02B
| $752K | ﹤0.01% |
69,951
+10,208
| +17% | +$109K |
|
|
MYOV
3640
DELISTED
Myovant Sciences Ltd.
MYOV
| $752K | ﹤0.01% |
+41,857
| New | +$668K |
|
3641
Aurinia Pharmaceuticals
AUPH
$1.92B
| $751K | ﹤0.01% |
99,837
-13,723
| -12% | -$119K |
|
3642
Burford Capital
BUR
$955M
| $750K | ﹤0.01% |
99,981
+8,317
| +9% | +$79.1K |
|
|
SUMO
3643
CALL
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $750K | ﹤0.01% |
100,000
| – | – |
|
|
CFLT
3644
CALL
DELISTED
Confluent
CFLT
| $749K | ﹤0.01% |
+31,500
| New | +$849K |
|
|
EXPR
3645
DELISTED
Express, Inc.
EXPR
| $746K | ﹤0.01% |
34,183
-29,016
| -46% | -$991K |
|
3646
American Financial Group
AFG
$12B
| $745K | ﹤0.01% |
6,061
+3,128
| +107% | +$410K |
|
3647
Merchants Bancorp
MBIN
$2.24B
| $743K | ﹤0.01% |
32,212
-6,966
| -18% | -$178K |
|
|
NEX
3648
CALL
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $740K | ﹤0.01% |
100,000
-3,000
| -3% | -$26.3K |
|
3649
Monster Beverage
MNST
$95.6B
| $738K | ﹤0.01% |
16,964
-62,088
| -79% | -$2.86M |
|
3650
ESAB
ESAB
$5.54B
| $737K | ﹤0.01% |
22,081
-3,814
| -15% | -$156K |
|
Similar funds
D.E. Shaw & Co's Q3 2022 Portfolio in Review
As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.
- D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
- D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
- D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.